MedPath

Efficacy and safety of levofloxacin infusion in patients with NHCAP categorized as group B or C according to the JRS Guidelines for the Management of Hospital-Acquired Pneumonia in Adults

Not Applicable
Conditions
ursing and Healthcare-Associated Pneumonia
Registration Number
JPRN-UMIN000011837
Lead Sponsor
Department of Respiratory Medicine,University of Occupational and Environmental Health, Japan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients receiving other treatments with clinical efficacy 2.Contraindication for levofloxacin 3.Patients deemed ineligible by the attending physicians for various reasons.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath